SCHEMBL776640

SCHEMBL776640

C=CS(=O)(=O)CCCCS(=O)(=O)C=C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
S1PR2 O95136 1/20 0.36
S1PR4 O95977 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
S1PR1 P21453 1/20 0.36
MAPK1 P28482 1/20 0.36
AGTR1 P30556 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2135110 0.97 NPC1 (0.35) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL2136773 0.97 NPC1 (0.35) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL1283388 0.93 NPC1 (0.36) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL7756252 0.89 NPC1 (0.31) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL547567 0.87 ALDH1A1 (0.50) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL9456781 0.87 APP (0.39) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL420429 0.86
SCHEMBL9457301 0.85
SCHEMBL10639166 0.84 FAAH (0.50) NPC1S1PR2S1PR4ALDH1A1LMNA
SCHEMBL11325650 0.84 FAAH (0.50) NPC1S1PR2S1PR4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12046717-B2 Nonaqueous electrolyte compositions comprising a fluorinated solvent and a 2-furanone SYENSQO SA (BE) 2024-07-23 US claimed
US-8404390-B2 Nonaqueous electrolyte solution for lithium secondary battery and lithium secondary battery using the same UBE INDUSTRIES, LTD. (JP) 2013-03-26 US claimed
US-12148889-B2 Non-aqueous electrolyteincluding lithium bis(fluorosulfonyl)imide, fluorinated acyclic carboxylic acid ester, organic carbonate and electrolyte salt SYENSQO SA (BE) 2024-11-19 US disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-12046717-B2 Nonaqueous electrolyte compositions comprising a fluorinated solvent and a 2-furanone SYENSQO SA (BE) 2024-07-23 US disclosed
EP-3513448-B1 ELECTROLYTES CONTAINING SIX MEMBERED RING CYCLIC SULFATES SYENSQO SA (BE) 2024-07-10 EP disclosed
EP-3738167-B1 NON-AQUEOUS ELECTROLYTE COMPOSITIONS COMPRISING LITHIUM BIS(FLUOROSULFONYL)IMIDE SYENSQO SA (BE) 2024-04-10 EP disclosed
US-20230395858-A1 NONAQUEOUS ELECTROLYTE COMPOSITIONS SOLVAY SA (BE) 2023-12-07 US disclosed
US-11773276-B2 Conductive polymer composition SOKEN CHEMICAL & ENGINEERING CO., LTD. (JP) 2023-10-03 US disclosed
EP-3332441-B1 NONAQUEOUS ELECTROLYTE COMPOSITIONS COMPRISING LITHIUM OXALATO PHOSPHATES SOLVAY (BE) 2023-08-09 EP disclosed
CN-109643827-B Non-aqueous electrolyte composition comprising silyl oxalate 索尔维公司 2023-02-07 CN disclosed
US-20090017277-A1 comprising a support; and an emulsion layer containing a silver salt emulsion, the photosensitive material being capable of forming a conductive metal film by exposing and developing the emulsion layer, wherein the emulsion layer has a swelling rate of 150% or more FUJIFILM CORPORATION (JP) 2009-01-15 US disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed
US-7446198-B2 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides BASF AKTIENGESELLSCHAFT (DE) 2008-11-04 US disclosed
US-20060229385-A1 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides BASF AKTIENGESELLSCHAFT (DE) 2006-10-12 US disclosed
US-20030035786-A1 Biological tissue adhesives, articles, and methods MEDTRONIC, INC. 2003-02-20 US disclosed
EP-0656564-B1 Imaging element for making a lithographic printing plate according to the silver salt diffusion transfer process AGFA GEVAERT NV (BE) 1998-04-01 EP disclosed
US-5512413-A HARDENED WITH DIVINYLSULFONYL HARDENER AGFA-GEVAERT N.V. (BE) 1996-04-30 US disclosed
EP-0656564-A1 Imaging element for making a lithographic printing plate according to the silver salt diffusion transfer process AGFA-GEVAERT N.V. (BE) 1995-06-07 EP disclosed
US-RE29305-E HARDENABLE HYDROPHILIC COLLOIDS, PHOTOGRAPHY EASTMAN KODAK COMPANY (US) 1977-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229385-A1 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides CBR3, NR2C2, NR0B2 NPC1 4003/4885S1PR2 681/4885S1PR4 828/4885
US-20030035786-A1 Biological tissue adhesives, articles, and methods ICAM1, EPCAM, VCAM1 NPC1 4844/4885S1PR2 1632/4885S1PR4 1854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.